Microfluidics Market Size, Emerging Trends and Overview to 2024: Hexa Reports

Submitted by: Submitted by

Views: 10

Words: 930

Pages: 4

Category: Business and Industry

Date Submitted: 10/03/2016 03:50 AM

Report This Essay

Hexa Reports

Market Research Reports and Insightful Company Profiles

Microfluidics Market Analysis, Share and Size, Emerging

Trends, Growth, Overview And Segment Forecasts To 2024

The global microfluidics market is expected to reach USD 10 billion by 2024, according to a new report

by Grand View Research, Inc. The demand for this sector is expected to upsurge due to the introduction

of improved technology, such as digital microfluidics, which enables on-chip biochemical analysis.

Industry players are introducing newer sampling technologies to meet the demand for screening a huge

number of biological samples. For instance, in March 2014, Dolomite launched Mitos Dropix capable of

generating miniature droplets to isolate contents. The patented droplet picking technology enables

high-throughput sample screening.

Browse Detail Report With TOC @ http://www.hexareports.com/report/microfluidics-market/details

Moreover, researchers are continuously striving to come up with improved sample droplet production

techniques. For instance, Columbia University introduced the picoliter fluid dispensation technology.

This lab-on-chip technology could deliver sample volume less than 50 nL. Integrating microfluidics with

multiplexed sensing technology allows multiple sample analytical application.

Further Key Findings From the Study Suggests:

In Vitro Diagnostic (IVD) segment dominated the application segment owing to the increasing adoption

of microfluidics in this market. Moreover, the leaders in the diagnostics sector, such as Abbott, Roche,

Hexa Reports

Market Research Reports and Insightful Company Profiles

and Danaher are encouraging the use of newer microfluidics technologies, such as the monodisperse

bubbles/drops.

Novel drug delivery system requires the administration of the drug in the form of nanoparticles, thereby

reducing the onset of action. Devices such as microneedles, pumps, and inhalers are expected to

experience fastest growth during the forecasted period....